A Phase 1 interventional study of EUR-1066-A and Zenpep in Chronic Pancreatitis, sponsored by Forest Laboratories. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-01-18.
Sponsored by Forest Laboratories (part of AbbVie) · Phase 1, Interventional, and Treatment
The purpose of this study is to evaluate two different treatments in subjects with chronic pancreatitis, exocrine pancreatic insufficiency and chronic abdominal pain.
To evaluate two different preparations of a pancreatic enzyme in subjects with chronic pancreatitis, exocrine pancreatic insufficiency, and chronic abdominal pain.
264 studies on the registry are indexed under Pancreatitis, Chronic; 76 are open to participants now.
This study's planned enrollment of 15 is below the median of 45 across 143 interventional studies indexed under Pancreatitis, Chronic.
Browse Pancreatitis, Chronic studies →Forest Laboratories is the lead sponsor of 168 studies on the registry; none are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 6 (100%) have results posted.
First submitted before Forest Laboratories became part of AbbVie.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Treatment with Eur-1006-A.
Drug: EUR-1066-A
Treatment with Eur-1066-B
Drug: EUR-1066-B
Control Group: Consist of treatment with Zenpep
Drug: Zenpep
Eur-1066 capsules taken daily for 28 days either during treatment period 1 or treatment period 3.
Also known as: EUR-1066
Capsules taken for daily for 28 days during treatment period 2
Eur-1066 capsules taken daily for 28 days either during treatment period 1 or treatment period 3.
Also known as: EUR-1066
Comparing frequency and severity of pain
Patient diary
Time frame: up to 84 days
Changes in fat malabsorption
Assess the coefficient of fat absorption
Time frame: up to 124 days
This study is terminated, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.